SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-19-000053
Filing Date
2019-01-11
Accepted
2019-01-11 07:20:28
Documents
13
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K aphria6k.htm 6-K 11883
2 FINANCIAL STATEMENTS ex991.htm EX-99.1 1158504
3 MANAGEMENT'S DISCUSSION AND ANALYSIS ex992.htm EX-99.2 489215
4 CEO AND CFO CERTIFICATES ex993.htm EX-99.3 16796
5 GRAPHIC footer.jpg GRAPHIC 4700
6 GRAPHIC pg4.jpg GRAPHIC 18941
7 GRAPHIC pg7_solei.jpg GRAPHIC 13833
8 GRAPHIC pg7_gf.jpg GRAPHIC 7446
9 GRAPHIC pg8.jpg GRAPHIC 10158
10 GRAPHIC pg7_riff.jpg GRAPHIC 4956
11 GRAPHIC pg7_gs.jpg GRAPHIC 5967
12 GRAPHIC pg9.jpg GRAPHIC 147036
13 GRAPHIC logo.jpg GRAPHIC 11069
  Complete submission text file 0001279569-19-000053.txt   1987227
Mailing Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8
Business Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8 (844) 427-4742
Aphria Inc. (Filer) CIK: 0001733418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-38708 | Film No.: 19521423
SIC: 2833 Medicinal Chemicals & Botanical Products